Physicians’ attitudes towards disclosure of payments from pharmaceutical companies in a nationwide voluntary transparency database: a cross-sectional survey

Physicians’ attitudes towards disclosure of payments from pharmaceutical companies in a nationwide voluntary transparency database: a cross-sectional survey

Objectives To investigate German physicians’ attitudes towards and experiences with voluntary disclosure of payments by pharmaceutical companies in a public database and their impact on future decisions for or against disclosure.Design A national cross-sectional survey conducted in 2018 among physic...

Descrizione completa

Dettagli Bibliografici
Autori principali:	Marlene Stoll, Lara Hubenschmid, Cora Koch, Klaus Lieb, Boris Egloff
Natura:	Articolo
Lingua:	English
Pubblicazione:	BMJ Publishing Group 2022-06-01
Serie:	BMJ Open
Accesso online:	https://bmjopen.bmj.com/content/12/6/e055963.full

Documenti analoghi

Voluntary disclosures of payments from pharmaceutical companies to healthcare professionals in Germany: a descriptive study of disclosures in 2015 and 2016
di: Marlene Stoll, et al.
Pubblicazione: (2020-09-01)

Assessing the impact of the Physician Payments Sunshine Act on pharmaceutical companies' payments to physicians.
di: Sherri Cheng, et al.
Pubblicazione: (2024-01-01)

The impact of using electronic payment methods on transparency and disclosure: Case study Jordanian companies
di: Aridah MAMOUN WALID, et al.
Pubblicazione: (2020-06-01)

Pharmaceutical industry payments to NHS trusts in England: A four-year analysis of the Disclosure UK database.
di: Piotr Ozieranski, et al.
Pubblicazione: (2023-01-01)

Pharmaceutical industry payments to NHS trusts in England: A four-year analysis of the Disclosure UK database
di: Piotr Ozieranski, et al.
Pubblicazione: (2023-01-01)

Voluntary disclosure with evolving news
di: Aghamolla, Cyrus, et al.
Pubblicazione: (2022)

Comparison of voluntary disclosure in Singapore.
di: Chan, Jean Siew Chen., et al.
Pubblicazione: (2008)

Voluntary disclosure in the biotechnology industry
di: Pan, Grace Meiyun, et al.
Pubblicazione: (2008)

Effect of voluntary disclosure on trading volume.
di: Chen, Huifen., et al.
Pubblicazione: (2008)

Impact of economic recession on voluntary disclosure.
di: Cheng, Lay Boon., et al.
Pubblicazione: (2008)

Voluntary disclosure and the volatility of security returns.
di: Chia, Chye Hua., et al.
Pubblicazione: (2008)

Voluntary disclosure of listed companies in Singapore.
di: Chang, Mun Ling., et al.
Pubblicazione: (2008)

Understanding voluntary disclosure: Malaysian perspective
di: Zaini Embong,
Pubblicazione: (2014)

Corporate governance and voluntary disclosure in Malaysia
di: Mohd Ghazali, Nazli Anum
Pubblicazione: (2010)

Voluntary disclosure of financial information on the Internet.
di: Chua, Shuh Luan., et al.
Pubblicazione: (2008)

Going Further in Combating Transnational Bribery: Voluntary Disclosure and Federal Transparency in America's Foreign Corrupt Practices Laws
di: Daniel Andrew Joseph
Pubblicazione: (2024-08-01)

Effects of enterprise risk management on voluntary disclosure and voluntary risk reporting.
di: Chow, Mun Jun., et al.
Pubblicazione: (2008)

The Effectiveness of the Voluntary Disclosure Program in Enhancing Voluntary Compliance among Individual Taxpayers
di: Erma Yunita, et al.
Pubblicazione: (2023-09-01)

Effects of corporate governance mechanisms on voluntary disclosure.
di: Geetha Sivaramakrishnam., et al.
Pubblicazione: (2008)

Essays on voluntary disclosure, information uncertainty and investment
di: Song, Q
Pubblicazione: (2023)

Corporate voluntary disclosure practices of banks in Bangladesh
di: Al Mamun, Syed Abdulla, et al.
Pubblicazione: (2014)

Factors influencing corporate voluntary disclosures in Malaysia
di: Ahmed Haji, Abdifatah, et al.
Pubblicazione: (2013)

Voluntary disclosure in Malaysian corporate annual reports
di: Mohd Ghazali, Nazli Anum
Pubblicazione: (2009)

Voluntary disclosure regime and its motivating factors
di: Chai, Ping Fong, et al.
Pubblicazione: (2008)

The value relevance of extent and sophistication of voluntary disclosure.
di: Foo, Yin Ling., et al.
Pubblicazione: (2008)

Framing and Gender in Voluntary Disclosure an Experimental Study
di: Siti Isnaniati, et al.
Pubblicazione: (2024-12-01)

Determinants of Voluntary Disclosure in Iran Capital Marke
di: Ali Rahmani, et al.
Pubblicazione: (2017-12-01)

Determinants of voluntary comprehensive income disclosure by U.S. firms.
di: Liew, Siew Fong., et al.
Pubblicazione: (2008)

Ownership structure and corporate voluntary disclosures in transition economy
di: Masum, Mofijul Hoq, et al.
Pubblicazione: (2020)

Voluntary disclosure behaviour of annual report award winners.
di: Fua, Qiu Lin., et al.
Pubblicazione: (2008)

Financial reporting quality and voluntary disclosures in private companies
di: Abdul-Jalil, A., et al.
Pubblicazione: (2015)

The impact of audit committee characteristics on corporate voluntary disclosure
di: Madi, Hisham Kamel, et al.
Pubblicazione: (2014)

Disclosure of voluntary accounting ratios by Malaysian listed companies
di: Abdullah, Azrul, et al.
Pubblicazione: (2005)

Disclosure of voluntary accounting ratios by Malaysian listed companies
di: Abdullah, Azrul, et al.
Pubblicazione: (2008)

Determinants of corporate voluntary disclosure in a transition economy
di: Masum, Mofijul Hoq, et al.
Pubblicazione: (2020)

Voluntary disclosure by Shariah approved companies: an exploratory study
di: Ousama, Abdulrahman Anam, et al.
Pubblicazione: (2010)

Voluntary Social Disclosure in an Emerging Country: The Case of Brazil
di: José Vale, et al.
Pubblicazione: (2024-12-01)

R&D tax allowance and voluntary information disclosures
di: Anna Białek-Jaworska, et al.
Pubblicazione: (2024-06-01)

Under-reported relationship: a comparative study of pharmaceutical industry and patient organisation payment disclosures in the UK (2012–2016)
di: Piotr Ozieranski, et al.
Pubblicazione: (2020-09-01)

The effect of market transparency on corporate disclosure
di: Rickmann, Georg(Georg Alexander)
Pubblicazione: (2021)